Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma.
Shimanuki M, Imanishi Y, Sato Y, Nakahara N, Totsuka D, Sato E, Iguchi S, Sato Y, Soma K, Araki Y, Shigetomi S, Yoshida S, Uno K, Ogawa Y, Tominaga T, Ikari Y, Nagayama J, Endo A, Miura K, Tomioka T, Ozawa H, Ogawa K.
Shimanuki M, et al. Among authors: ozawa h.
Oncotarget. 2018 Apr 10;9(27):18970-18984. doi: 10.18632/oncotarget.24863. eCollection 2018 Apr 10.
Oncotarget. 2018.
PMID: 29721176
Free PMC article.